Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Blast morphological abnormalities in de novo acute myeloid leukemia (excluding acute promyelocytic leukemia): associations with genetic alterations and diagnostic value of pseudo-Chediak-Higashi inclusions for the t(8;21) translocation].

Created on 31 Oct 2026

Authors

Ajeeva Ithayakumar, Eric Guiheneuf

Published in

Annales de biologie clinique. Volume 84. Issue 5. Pages 0. Oct 31, 2026. Epub Oct 31, 2026.

Abstract

Blast morphology remains a key step in the initial diagnosis of acute myeloid leukemia (AML). Several morphological abnormalities have been associated with specific genetic alterations, but their frequency and predictive value remain incompletely characterized. This retrospective single-center study included 102 patients with de novo AML (excluding acute promyelocytic leukemia) diagnosed at Amiens University Hospital between 2019 and 2024. Bone marrow smears were reviewed to identify blast morphological abnormalities and their associations with cytogenetic and molecular alterations. An additional cohort of patients with the t(8;21) translocation (n = 11) was analyzed to further investigate pseudo-Chediak-Higashi inclusions. At least one morphological abnormality was observed in 67.6% of patients. Cup-like nuclei (6.9%) were exclusively associated with NPM1 mutations (100%; p < 0.001). Convoluted nuclei (40.2%) were associated with monocytic AML (M4/M5) and with NPM1 mutations and the CBFβ::MYH11 fusion transcript. Pseudo-Chediak-Higashi inclusions (19.6%) were significantly associated with the RUNX1::RUNX1T1 transcript in the main cohort (sensitivity 80%; specificity 83.5%; PPV 20.0%; p = 0.005). Cytoplasmic vacuoles (8.8%) were significantly associated with monocytic AML M5 (p = 0.017). Blast morphology remains a useful tool for the early diagnostic orientation of AML. The presence of pseudo-Chediak-Higashi inclusions may suggest the RUNX1::RUNX1T1 fusion, while cup-like nuclei strongly indicate the presence of an NPM1 mutation during the initial examination of the bone marrow smear.

PMID:
42963915
Bibliographic data and abstract were imported from PubMed on 31 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 18
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement